Intellia Therapeutics
NTLA
NTLA
371 hedge funds and large institutions have $7.59B invested in Intellia Therapeutics in 2021 Q4 according to their latest regulatory filings, with 66 funds opening new positions, 126 increasing their positions, 118 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more ownership
Funds ownership: →
7% more repeat investments, than reductions
Existing positions increased: 126 | Existing positions reduced: 118
9% less capital invested
Capital invested by funds: $8.34B → $7.59B (-$748M)
28% less call options, than puts
Call options by funds: $44.1M | Put options by funds: $61.3M
Holders
371
Holding in Top 10
9
Calls
$44.1M
Puts
$61.3M
Top Buyers
| 1 | +$147M | |
| 2 | +$87.4M | |
| 3 | +$47.3M | |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$44.3M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
+$44.3M |
Top Sellers
| 1 | -$49.8M | |
| 2 | -$33.7M | |
| 3 | -$30.6M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$24.3M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$22.2M |